Retour
Fourchette du Jour
34,57 €
36,77 €
Fourchette 52 Semaines
23,23 €
50,79 €
Volume
526 314
Moyenne 50J / 200J
43,32 €
/
38,94 €
Clôture Précédente
35,44 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 17,5 | 0,4 |
| P/B | 3,7 | 2,9 |
| ROE % | 23,7 | 3,8 |
| Net Margin % | 8,1 | 3,9 |
| Rev Growth 5Y % | 29,6 | 10,0 |
| D/E | 3,1 | 0,2 |
Points Clés
Revenue grew 29,58% annually over 5 years — strong growth
ROE of 23,70% indicates high profitability
Debt/Equity of 3,12 — high leverage
Generating 327,58M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 5,96%
Cash machine — converts 521,05% of earnings into free cash flow
Croissance
Revenue Growth (5Y)
29,58%
Revenue (1Y)23,62%
Earnings (1Y)-9,13%
FCF Growth (3Y)9,28%
Qualité
Return on Equity
23,70%
ROIC11,30%
Net Margin8,05%
Op. Margin23,97%
Sécurité
Debt / Equity
3,12
Current Ratio1,57
Interest Coverage2,27
Valorisation
P/E Ratio
17,54
P/B Ratio3,66
EV/EBITDA9,58
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 23,62% | Revenue Growth (3Y) | 17,36% |
| Earnings Growth (1Y) | -9,13% | Earnings Growth (3Y) | 14,26% |
| Revenue Growth (5Y) | 29,58% | Earnings Growth (5Y) | -3,17% |
| Profitability | |||
| Revenue (TTM) | 780,57M | Net Income (TTM) | 62,87M |
| ROE | 23,70% | ROA | 3,79% |
| Gross Margin | 59,35% | Operating Margin | 23,97% |
| Net Margin | 8,05% | Free Cash Flow (TTM) | 327,58M |
| ROIC | 11,30% | FCF Growth (3Y) | 9,28% |
| Safety | |||
| Debt / Equity | 3,12 | Current Ratio | 1,57 |
| Interest Coverage | 2,27 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 17,54 | P/B Ratio | 3,66 |
| P/S Ratio | 1,41 | PEG Ratio | -3,12 |
| EV/EBITDA | 9,58 | Dividend Yield | 0,00% |
| Market Cap | 1,10B | Enterprise Value | 1,79B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 780,57M | 631,45M | 566,77M | 463,93M | 276,87M |
| Net Income | 62,87M | 69,19M | 48,16M | -25,00M | 71,52M |
| EPS (Diluted) | 1,73 | 1,86 | 1,29 | -0,74 | 1,86 |
| Gross Profit | 463,26M | 377,34M | 326,17M | 209,49M | 150,62M |
| Operating Income | 187,08M | 169,90M | 166,96M | 33,32M | 17,63M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,66B | 1,66B | 1,14B | 1,17B | 692,08M |
| Total Liabilities | 1,36B | 1,43B | 947,88M | 979,29M | 489,15M |
| Shareholders' Equity | 301,68M | 228,84M | 195,43M | 194,84M | 202,93M |
| Total Debt | 940,56M | 859,30M | 674,28M | 709,18M | 258,75M |
| Cash & Equivalents | 251,10M | 70,57M | 238,95M | 173,69M | 186,43M |
| Current Assets | 691,41M | 482,26M | 537,60M | 419,99M | 315,54M |
| Current Liabilities | 440,03M | 509,51M | 457,92M | 433,73M | 279,57M |